“…Of 21 isolates tested, all were susceptible to doxycycline, linezolid, and moxifloxacin according to the published report or Clinical and Laboratory Standards Institute broth microdilution interpretive criteria for RGM. Most isolates were susceptible to amikacin (17 of 18 isolates), cefoxitin (12 of 13), ciprofloxacin (15 of 16), imipenem (14 of 15), and meropenem (3 of 3) (Table) (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23). Isolates were less reliably susceptible to TMP/SMX (10 of 15 isolates) and clarithromycin (7 of 15).…”